Literature DB >> 2374740

A replication-deficient HIV-1 DNA used for quantitation of the polymerase chain reaction (PCR).

C Hart1, S Y Chang, S Kwok, J Sninsky, C Y Ou, G Schochetman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2374740      PMCID： PMC331144          DOI： 10.1093/nar/18.13.4029

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  3 in total

1.  Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.

Authors:  H G Göttlinger; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Active human immunodeficiency virus protease is required for viral infectivity.

Authors:  N E Kohl; E A Emini; W A Schleif; L J Davis; J C Heimbach; R A Dixon; E M Scolnick; I S Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

3.  Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity.

Authors:  C Peng; B K Ho; T W Chang; N T Chang
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103
  3 in total
  9 in total

1.  Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications.

Authors:  Q Chou; M Russell; D E Birch; J Raymond; W Bloch
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

2.  The effects of internal primer-template mismatches on RT-PCR: HIV-1 model studies.

Authors:  C Christopherson; J Sninsky; S Kwok
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

3.  Selective amplification of RNA utilizing the nucleotide analog dITP and Thermus thermophilus DNA polymerase.

Authors:  T Auer; J J Sninsky; D H Gelfand; T W Myers
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

4.  Increased reliability of selective PCR by using additionally mutated primers and a commercial Taq DNA polymerase enhancer.

Authors:  A De Milito; M Catucci; F Iannelli; L Romano; M Zazzi; P E Valensin
Journal:  Mol Biotechnol       Date:  1995-04       Impact factor: 2.695

5.  Zidovudine resistance mutations and human immunodeficiency virus type 1 DNA burden: longitudinal evaluation of six patients under treatment.

Authors:  M Zazzi; M Catucci; A De Milito; L Romano; G Venturi; P Almi; A Gonnelli; M Rubino; P E Valensin
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

6.  Low human immunodeficiency virus type 1 (HIV-1) DNA burden as a major cause for failure to detect HIV-1 DNA in clinical specimens by PCR.

Authors:  M Zazzi; L Romano; M Catucci; A De Milito; P Almi; A Gonnelli; M Rubino; P E Valensin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

7.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase.

Authors:  P M Holland; R D Abramson; R Watson; D H Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

8.  Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC).

Authors:  Paolo Palma; Maria Luisa Romiti; Carla Montesano; Veronica Santilli; Nadia Mora; Angela Aquilani; Stefania Dispinseri; Hyppolite K Tchidjou; Marco Montano; Lars E Eriksson; Stefania Baldassari; Stefania Bernardi; Gabriella Scarlatti; Britta Wahren; Paolo Rossi
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

9.  Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.

Authors:  Matteo Surdo; Emanuela Balestra; Patrizia Saccomandi; Fabiola Di Santo; Marco Montano; Domenico Di Carlo; Loredana Sarmati; Stefano Aquaro; Massimo Andreoni; Valentina Svicher; Carlo Federico Perno; Francesca Ceccherini-Silberstein
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.